Filing Details
- Accession Number:
- 0001209191-21-003244
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-12 16:34:52
- Reporting Period:
- 2021-01-08
- Accepted Time:
- 2021-01-12 16:34:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107421 | Ziopharm Oncology Inc | ZIOP | Pharmaceutical Preparations (2834) | 841475642 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1429559 | G Kevin Lafond | C/O Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129 | Svp, Treasurer & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-08 | 18,020 | $3.09 | 63,965 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants.
Billionaire Hedge Funds
